Jeffrey S. Heier

Ophthalmic Consultants of Boston — United States

Medicine · Health Sciences

72h-index33.9kcitations296works24.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(197), Retinal Imaging and Analysis(114), Retinal and Optic Conditions(111), Glaucoma and retinal disorders(58), Retinal and Macular Surgery(38)

Publications285 total

Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial
Japanese Journal of Ophthalmology·2025Open Access
Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration
Ophthalmology·2025Open Access
Correction: Functional and Anatomical Outcomes of Faricimab in Previously Treated Wet Age-Related Macular Degeneration: Systematic Review and Pooled Analysis
Ophthalmology and Therapy·2025Open Access
Functional and Anatomical Outcomes of Faricimab in Previously Treated Wet Age-Related Macular Degeneration: Systematic Review and Pooled Analysis
Ophthalmology and Therapy·2025· 2 citedOpen Access
REPLY
Ophthalmology·2025Open Access
Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration
Therapeutic Advances in Ophthalmology·2025Open Access
Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE
American Journal of Ophthalmology·2025· 6 citedOpen Access
Pivotal Trial Validating Usability and Visualization Performance of Home OCT in Neovascular Age-Related Macular Degeneration: Report 1
Ophthalmology Science·2025· 6 citedOpen Access
Gene therapy for AMD: better as an adjuvant than a replacement – Authors' reply
The Lancet·2025
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies
Immunotherapy·2025· 1 citedOpen Access
Infographic: Efficacy and safety of high-dose Intravitreal aflibercept 8 mg in patients with neovascular age-related macular degeneration: week 48 results from the phase 3 PULSAR trial
Eye·2025Open Access
Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration
Journal of VitreoRetinal Diseases·2024· 10 citedOpen Access
Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2—Artificial Intelligence Analytics
Ophthalmology Science·2024· 11 citedOpen Access
ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation
Ophthalmology Science·2024· 19 citedOpen Access
MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
Ophthalmology·2024· 12 citedOpen Access
Visual and Anatomic Responses in Patients With Neovascular Age-Related Macular Degeneration and a Suboptimal Response to Anti-VEGF Therapy Switched to Faricimab
Journal of VitreoRetinal Diseases·2024· 9 citedOpen Access
Ultra-Widefield and Early Treatment Diabetic Retinopathy Study 7-Field Grading of Diabetic Retinopathy
JAMA Ophthalmology·2024· 3 citedOpen Access
Phase 1 Study of JNJ-81201887 Gene Therapy in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Ophthalmology·2024· 21 citedOpen Access
Syfovre Approval for Geographic Atrophy
JAMA Ophthalmology·2024
Future Therapies
2024
page 1 of 15Next →

Frequent Co-authors

David S. Boyer(19), David M. Brown(18), Robert Vitti(13), Alyson J. Berliner(13), Peter K. Kaiser(12), Peter A. Campochiaro(10), Frank G. Holz(9), Philip J. Rosenfeld(8), Jean‐François Korobelnik(8), Quan Dong Nguyen(8), Glenn J. Jaffe(8), David M. Brown(7), George D. Yancopoulos(7), Yuhwen Soo(7), Julia A. Haller(7), Oliver Zeitz(7), Charles C. Wykoff(7), W. Lloyd Clark(7), Ursula Schmidt‐Erfurth(6), Jason S. Slakter(6)